Skip to main content
Top
Published in: Rheumatology International 3/2011

01-03-2011 | Original Article

Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis

Authors: Şehim Kutlay, Ayşe A. Küçükdeveci, Atilla H. Elhan, Derya Öztuna, Nihal Koç, Alan Tennant

Published in: Rheumatology International | Issue 3/2011

Login to get access

Abstract

The objective of this study is to test the reliability and validity of WHODAS-II (Turkish version) for the assessment of disability in patients with osteoarthritis. This study is designed as follows: the internal construct validity of WHODAS-II in patients with knee osteoarthritis was assessed by Rasch analysis, and external construct validity by association with the Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC) and the Nottingham Health Profile (NHP); reliability was tested by internal consistency, intra-class correlation coefficient (ICC) and test–retest ICC. Our study presents the results of 225 outpatients assessed with mean age 58.4 years (SD 11.1) of whom 80.9% were female. Cronbach’s α, ICC, and test–retest ICC values for the six subscales of WHODAS-II varied between 0.71 and 0.94, 0.71 and 0.94, and 0.87 and 0.97, respectively. Rasch analysis of WHODAS-II indicated that after adjustment for local dependency, satisfactory fit was achieved. Two separate ‘activities’ and ‘participation’ components could also be identified. External construct validity of the scale was confirmed with expected correlations with WOMAC and NHP. This study concludes that WHODAS-II provides a reliable and valid health status instrument for measuring disability and components of ‘activities’ and ‘participation’ in patients with osteoarthritis. Thus, it provides the opportunity to model the consequences of disease according to the International Classification of Functioning, Disability and Health framework.
Literature
1.
go back to reference Reginster JY (2002) The prevalence and burden of osteoarthritis. Rheumatol 41(1):3–6CrossRef Reginster JY (2002) The prevalence and burden of osteoarthritis. Rheumatol 41(1):3–6CrossRef
2.
go back to reference Botha-Scheepers S, Riyazi N, Kroon HM, Scharloo M, Houwing-Duistermaat JJ, Slagboom E et al (2006) Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health. Osteoarthr Cartil 14(11):1104–1110CrossRefPubMed Botha-Scheepers S, Riyazi N, Kroon HM, Scharloo M, Houwing-Duistermaat JJ, Slagboom E et al (2006) Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health. Osteoarthr Cartil 14(11):1104–1110CrossRefPubMed
3.
go back to reference World Health Organization (2001) International classification of functioning, disability and Health (ICF). World Health Organization, Geneva World Health Organization (2001) International classification of functioning, disability and Health (ICF). World Health Organization, Geneva
5.
go back to reference Chwastiak LA, Von Korff M (2003) Disability in depression and back pain. Evaluation of WHODAS-II in a primary care setting. J Clin Epidemiol 56(6):507–514CrossRefPubMed Chwastiak LA, Von Korff M (2003) Disability in depression and back pain. Evaluation of WHODAS-II in a primary care setting. J Clin Epidemiol 56(6):507–514CrossRefPubMed
6.
go back to reference van Tubergen A, Landewé R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H (2003) Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 62:140–145CrossRefPubMed van Tubergen A, Landewé R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H (2003) Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 62:140–145CrossRefPubMed
7.
go back to reference Schlote A, Richter M, Wunderlich MT, Poppendick U, Möller C, Wallesch CW (2009) WHODAS-II with people after stroke and their relatives. Disabil Rehabil 31(11):855–864CrossRefPubMed Schlote A, Richter M, Wunderlich MT, Poppendick U, Möller C, Wallesch CW (2009) WHODAS-II with people after stroke and their relatives. Disabil Rehabil 31(11):855–864CrossRefPubMed
8.
go back to reference Pösl M, Cieza A, Stucki G (2007) Psychometric properties of the WHODAS-II in rehabilitation patients. Qual Life Res 16(9):1521–1531CrossRefPubMed Pösl M, Cieza A, Stucki G (2007) Psychometric properties of the WHODAS-II in rehabilitation patients. Qual Life Res 16(9):1521–1531CrossRefPubMed
9.
go back to reference Ulug B, Ertugrul A, Gogus A, Kabakcı E (2001) Yetiyitimi degerlendirme cizelgesinin (WHODAS-II) sizofreni hastalarında gecerlilik ve güvenilirligi. Turk Psikiyatr Derg 12:121–130 Ulug B, Ertugrul A, Gogus A, Kabakcı E (2001) Yetiyitimi degerlendirme cizelgesinin (WHODAS-II) sizofreni hastalarında gecerlilik ve güvenilirligi. Turk Psikiyatr Derg 12:121–130
10.
go back to reference Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33CrossRefPubMed Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33CrossRefPubMed
11.
go back to reference European Group for Quality of Life Assessment and Health Measurement (1993) European Guide for Nottingham Health Profile. Brookwood Medical Publications, Surrey European Group for Quality of Life Assessment and Health Measurement (1993) European Guide for Nottingham Health Profile. Brookwood Medical Publications, Surrey
12.
go back to reference Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38CrossRefPubMed Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38CrossRefPubMed
13.
go back to reference Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef
14.
go back to reference Streiner DL, Norman GR (1995) Health measurement scales. Oxford University Press, Oxford Streiner DL, Norman GR (1995) Health measurement scales. Oxford University Press, Oxford
15.
go back to reference Luce RD, Tukey JW (1964) Simultaneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1:1–27CrossRef Luce RD, Tukey JW (1964) Simultaneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1:1–27CrossRef
16.
go back to reference Perline R, Wright BD, Wainer H (1979) The Rasch model as additive conjoint measurement. Appl Psychol Meas 3:237–256CrossRef Perline R, Wright BD, Wainer H (1979) The Rasch model as additive conjoint measurement. Appl Psychol Meas 3:237–256CrossRef
17.
go back to reference Rasch G (1960) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago Rasch G (1960) Probabilistic models for some intelligence and attainment tests. University of Chicago Press, Chicago
18.
go back to reference Andrich D (1978) Rating formulation for ordered response categories. Psychometrika 43:561–573CrossRef Andrich D (1978) Rating formulation for ordered response categories. Psychometrika 43:561–573CrossRef
19.
go back to reference Masters GN (1982) A Rasch model for partial credit scoring. Psychometrika 47:149–174CrossRef Masters GN (1982) A Rasch model for partial credit scoring. Psychometrika 47:149–174CrossRef
20.
go back to reference Tennant A, Conaghan PG (2007) The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57:1358–1362CrossRefPubMed Tennant A, Conaghan PG (2007) The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57:1358–1362CrossRefPubMed
21.
go back to reference Marais I, Andrich D (2008) Formalizing dimension and response violations of local independence in the unidimensional Rasch model. J Appl Meas 9:200–215PubMed Marais I, Andrich D (2008) Formalizing dimension and response violations of local independence in the unidimensional Rasch model. J Appl Meas 9:200–215PubMed
22.
go back to reference Wainer H, Kiely GL (1987) Item clusters and computer adaptive testing: a case for testlets. J Educ Meas 24:185–210CrossRef Wainer H, Kiely GL (1987) Item clusters and computer adaptive testing: a case for testlets. J Educ Meas 24:185–210CrossRef
23.
go back to reference Smith EV (2002) Detecting and evaluation the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3:205–231PubMed Smith EV (2002) Detecting and evaluation the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3:205–231PubMed
24.
go back to reference Linacre JM (1994) Sample size and item calibration stability. Rasch Meas Trans 7:28 Linacre JM (1994) Sample size and item calibration stability. Rasch Meas Trans 7:28
25.
go back to reference Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310:170PubMed Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310:170PubMed
26.
go back to reference Andrich D, Lyne A, Sheridan B, Luo G (2003) RUMM 2020. Perth: RUMM Laboratory Duncraig, Western Australia Andrich D, Lyne A, Sheridan B, Luo G (2003) RUMM 2020. Perth: RUMM Laboratory Duncraig, Western Australia
27.
go back to reference Weigl M, Cieza A, Harder M, Amann E, Kostanjsek N, Stucki G (2003) Linking osteoarthritis-specific health status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthr Cartil 11(7):519–523CrossRefPubMed Weigl M, Cieza A, Harder M, Amann E, Kostanjsek N, Stucki G (2003) Linking osteoarthritis-specific health status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthr Cartil 11(7):519–523CrossRefPubMed
28.
go back to reference Dreinhofer K, Stuki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF core sets for osteoarthritis. J Rehabil Med (Suppl 44):75–80 Dreinhofer K, Stuki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF core sets for osteoarthritis. J Rehabil Med (Suppl 44):75–80
Metadata
Title
Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis
Authors
Şehim Kutlay
Ayşe A. Küçükdeveci
Atilla H. Elhan
Derya Öztuna
Nihal Koç
Alan Tennant
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1306-8

Other articles of this Issue 3/2011

Rheumatology International 3/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.